What about those lawsuits anyways...remember the judge coaching the plaintiff to "concentrate on lack of adequate disclosure by management" they're doing it again.....keeping shareholders in the dark.
Almost all biotechs report on interim data results. Keeps investors from all bailing midpoint through the trials. Why does Gern always keep us investors in the dark?
Thanks to Chippy's top talented high priced management team.
No milestone payments
No trial data update
No sense of ownership till next year
How is this possible.
Why would anyone invest in Gern right now other than to short it? For that the hedge funds owe Chippy' one for the next shelf distribution
quit with the political rhetoric for once. I can bring myself to agreeing with your assessment of GERN's pathetic shareholder unfriendly management but when it comes to all the other stuff I begin to question my judgement on this company's board of directors. Unless of course that is you agenda here. It's working Weddgie
quit the #$%$ Circone we're up a whole cent. None of this makes any cents especially Chippy's self made $1.03 mil salary pkg, not to mention his 6-7.5mil free share options
notice how need more ham never matched their target?
well when you consider GERN is dropping 3x the cent value of MEIP Meip must be 3x a better (money losing) investment than GERN unless of course you are short, then by far GERN is the all time winner, down 50% from year's start and dropping.
yes Rocky we should all be celebrating the 50% haircut we as shareholders have endured since 2013 after favourable ASH trial presentation results. Chippy's done a bang up job preserving shareholder's equity
Geron announces the purchase of a Porsche dealership thereby exercising another 20mil share to make it an even 180mil outstanding. With this acquisition the high priced talent at Menlo Park should be able to shave several minutes off their commute time there bye increasing their availability to shareholders for an additional 0 minutes as is currently the case.